NASDAQ:QCOM

Qualcomm (QCOM)

168.74
+0.17 (0.10%)
as of Sep 4, 2026, 8:00:00 pm Market Open.
371 watching
0
Investor Insights
star iconSep 5, 2026, 12:00 am

This summary was created by AI, based on 7 opinions in the last 12 months.

Qualcomm (QCOM-Q) is experiencing a complex landscape, as indicated by varied expert reviews. Historically the largest player in the smartphone semiconductor market, Qualcomm's growth has been impeded by diminishing ties with key customers like Apple, leading to concerns about its future prospects. While some believe there is notable AI potential and advancements in sectors like automotive and IoT, others suggest that the stock is priced for stagnation, especially given its high forward price-to-earnings ratio compared to peers. The recent surge in stock value, a significant 76% over the past year, has raised questions about its sustainability, with experts suggesting it could be a good time to trim positions. Ultimately, there seems to be a divergence between its current valuation and realistic growth expectations, prompting a cautious perspective from various analysts.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Undervalued
review icon
Similar
NVDA
DON'T BUY
Their income is based on royalties. Too expensive.
BUY
Has rolyalties coming in from phone chips, but phone sales are down. Will be a survivor.
TOP PICK
Top Short Trades at 30/35 X earnings. Hand sets are slow. Wait for the top of the current run before shorting.
DON'T BUY
Not for the short term, but Ok for long term.
DON'T BUY
Good companu and a leader, but its customers are limiting their spending.
DON'T BUY
Could drop further.Would like to see how they do in China.
DON'T BUY
Stock is not acting strong. Too high a valuation.
BUY
Has good patents. Focusing on China. A good price. May go lower, but will be very good in a years time.
STRONG BUY
A leader in the wireless sector. Good royalties.
BUY
Should do well over the long term.
DON'T BUY
Not a fan of the telecom sector.
DON'T BUY
Owns good patents, but royalties are questionable.
BUY ON WEAKNESS
Buy at $40.
DON'T BUY
Expanding into Asia. Well managed. Have to see how they do in their expansion.
PAST TOP PICK
(Was a top pick on Aug 20 down 16%) Still buying.
Showing 391 to 405 of 409 entries